CCR2 and rheumatoid arthritis: In addition, the blockade of CCL2 receptor CCR2 via human CCR2 blocking antibodies displayed up to 94% reduction of free CCR2 on monocytes, but without an amelioration of synovial inflammation in rheumatoid arthritis [115].